Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
5.28
+0.05 (0.96%)
Nov 20, 2024, 4:00 PM EST - Market closed
Outlook Therapeutics Employees
Outlook Therapeutics had 24 employees as of September 30, 2023. The number of employees increased by 7 or 41.18% compared to the previous year.
Employees
24
Change (1Y)
7
Growth (1Y)
41.18%
Revenue / Employee
n/a
Profits / Employee
-$3,918,698
Market Cap
124.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
American Well | 1,104 |
Protalix BioTherapeutics | 208 |
Cibus | 183 |
Repare Therapeutics | 179 |
Zomedica | 144 |
Vigil Neuroscience | 69 |
Compugen | 68 |
Avalo Therapeutics | 19 |
OTLK News
- 14 days ago - Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference - GlobeNewsWire
- 2 months ago - Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series - GlobeNewsWire
- 2 months ago - Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series - GlobeNewsWire
- 2 months ago - Outlook Therapeutics® Announces Completion of Enrollment in NORSE EIGHT Clinical Trial - GlobeNewsWire
- 2 months ago - Outlook Therapeutics® to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Outlook Therapeutics: Poised To Jump With Wet AMD Treatment If It Can Overcome FDA Hurdles - Seeking Alpha
- 3 months ago - Outlook Therapeutics, Inc. (OTLK) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - GlobeNewsWire